Prenetics Global signs "transformational" $200mln deal to create cancer screening JV

By: TheNewswire.com

June 30, 2023 at 08:00 AM EDT

Prenetics Global Ltd (NASDAQ: PRE) CEO Danny Yeung speaks to Thomas Warner from Proactive after announcing a $200mln deal to create a multi-cancer early detection screening joint venture with Professor Dennis Lo. The new JV will be called Insighta and Yeung will serve as its first CEO. Yeung reveals plans to launch tests targeting lung and liver cancer in 2025, with a goal of selling over 30 million tests annually by 2030.

Contact Details

Proactive United States

Proactive United States

+1 347-449-0879

action@proactiveinvestors.com

More News

Holiday Spending to Hit $1 Trillion—Time to Buy This Retail ETF? ↗

Today 12:22 EST

Via MarketBeat

BJ’s Wholesale Club and the Case for a Bullish Market Reversal ↗

Today 11:45 EST

Via MarketBeat

Why Costco Stock May Struggle Even as Its Business Thrives ↗

Today 10:31 EST

Via MarketBeat

Broadcom’s Best Catalyst Yet Might Be Hiding in 2026 Forecasts ↗

Today 9:10 EST

Via MarketBeat

3 High Growth Revenue Stocks That Wall Street Loves ↗

Today 8:21 EST

Via MarketBeat

Recent Quotes

Symbol	Price	Change (%)
AMZN	224.71	+4.02 (1.82%)
AAPL	275.12	+3.63 (1.34%)
AMD	214.43	+10.65 (5.22%)
BAC	51.88	+0.31 (0.61%)
GOOG	314.72	+15.07 (5.03%)
META	613.18	+18.93 (3.19%)
MSFT	475.58	+3.46 (0.73%)
NVDA	182.17	+3.29 (1.84%)
ORCL	199.64	+0.88 (0.44%)
TSLA	418.76	+27.68 (7.08%)

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.